At MDLifespan, we are a physician-led, expert team of clinicians focused exclusively on therapeutic plasma exchange (TPE). Our patent pending PlasmaXchange Protocols, which range from three to five treatments, reduce several synthetic chemicals from the body, promoting longevity and reduction of inflammatory markers.
Our clinical study, focused on environmental toxins, found that PlasmaXchange Protocols reduce BPA by 71.5%, phthalates by 75.7% and glyphosate by 68%.

